Mexidol® for chronic brain ischemia / discirculatory encephalopathy

Time codes:
  • 00:00

    Pathogenesis of chronic brain ischemia

  • 00:33

    The causes of chronic brain ischemia

  • 01:07

    Mexidol® drug with brain ischemic

Sokolova Lyubov Petrovna - MD, professor of the Department of Neurology of the FDPO RNIMU named after N.I. Pirogov

Announcement:

Chronic brain ischemia is a pathology characterized by the inconsistency between the blood supply to the brain tissue and its need for oxygen and nutrients. This condition can occur against the background of atherosclerosis of the vessels of the brain and the stenosis process, against the background of microangiopathy for hypertension. Endothelial dysfunction, neurogenic inflammation, oxidative stress - all this leads to the fact that tissue blood supply is not adequate enough. And it is necessary to choose a drug that would act on all these links of pathogenesis. The drug Mexidol ® is the same drug of choice, because it has an antihypoxic, antioxidant and membraneoprotective effect. It affects vascular risk factors, on hyperglycemia, to arterial hypertension to some extent. The drug has nootropic, anxiolytic and anti -alert effect, normalizes sleep. Also, the drug has a heroome effect. Mexidol ® is a drug of choice for the treatment of chronic brain ischemia.

Block of articles on this topic

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

Authors:
A.I. Fedin 1 , V.V. Zakharov 2 , M.M. Tanashian 3 , E.I. Chukanova 1 , E.N. Majidova 4 , L.A. Shchepankevich 5.6 , O.D. Ostroumova 7

The effectiveness of Mexidol in patients of different age groups with chronic brain ischemia with cognitive disorders (the results of subanalysis of the international multicenter randomized double blind placebo-controlled study of memes)

Authors:
V.V. Zakharov 1 , O.N. Tkacheva 2, 3 , E.A. Mkhitaryan 2, 3 , A.I. Fedin 2

Safety Mexidol® (ethylmethylhydroxypyridine of succinate) in adult patients of different age groups

Authors:
E.A. Ushkalova 1 , S.K. Zyryanov 1.2 , O.I. Buttranova 1

1 FGAOU VO “Russian University of Friendship of Peoples”
2 GBUZ “City Clinical Hospital No. 24 of the Department of Health of the city of Moscow”

International multicenteric randomized double-tied placebo-controlled study of evaluating the effectiveness and safety of sequential therapy of patients with chronic brain ischemia drugs Mexidol® and Mexidol® Forte 250 (study of memo): Subanalysis results in patients with arterial hypertension

Authors:
V.V. Zakharov 1 , O.D. Ostroumova 1.2 , A.I. Kochetkov 2 , M.V. Klepikov 2 , A.I. Fedin 3

The effectiveness and safety of the drug Mexol Forte 250 in the framework of consecutive therapy in patients with chronic brain ischemia

Author:
E.I. Chukanova, A.S. Chukanova

Department of Neurology, Neurosurgery and Medical Genetics of Faculty of Faculty of Faculty of FSBEI in "RNIMU named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com